Treatment of facial lipoatrophy in HIV-infected patients.
Standard management for facial lipoatrophy caused by antiretroviral drugs includes switching drugs and surgical autografting of adipose tissue. Local injections of polylactic acid have not been compared with surgery. Benefits usually seem to outweigh adverse effects in the short term but few long-term results are available.
D000273:Adipose Tissue / Q000637:transplantation*; D044966:Anti-Retroviral Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D003357:Cosmetic Techniques; D005145:Face / Q000503:physiopathology / Q000601:surgery* / Q000821:virology; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D007273:Injections, Intramuscular; D019344:Lactic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008055:Lipids / Q000627:therapeutic use*; D011108:Polymers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013518:Surgery, Plastic / Q000009:adverse effects
D044966:Anti-Retroviral Agents; D008055:Lipids; D011108:Polymers; D019344:Lactic Acid